Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration

Human Gene Therapy

Volumn 10, Issue 10, 1999, Pages 1683-1694

  Barron, Lee G ^a   Gagné, Lucie ^a   Szoka Jr , Francis C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LIPID; LIPOSOME; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; FEMALE; GENE EXPRESSION; GENE TARGETING; LIVER; LUNG; LUNG BLOOD VESSEL; MOUSE; NONHUMAN; REPORTER GENE;

ANIMALS; ANIONS; CATIONS; DRUG CARRIERS; FEMALE; GENE TRANSFER TECHNIQUES; INJECTIONS, INTRAVENOUS; LIPIDS; LIPOSOMES; LUCIFERASES; LUNG; MICE; PLASMIDS; TIME FACTORS;

EID: 0033166721     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950017680     Document Type: Article

References (38)

1. ABRA, R.M., SCHREIER, H., and SZOKA, F.C. (1982). The use of a new radioactive-iodine labeled lipid marker to follow in vivo disposition of liposomes: Comparison with an encapsulated aqueous space marker. Res. Commun. Chem. Pathol. Pharmacol. 37, 199-213.
2. BARRON, L.G., MEYER, K.B., and SZOKA, F.C., JR. (1998). Effects of complement depletion on the pharmacokinetics and gene delivery mediated by cationic lipid-DNA complexes. Hum. Gene Ther. 9, 315-323.
3. BOTTEGA, R., and EPAND, R.M. (1992). Inhibition of protein kinase C by cationic amphiphiles. Biochemistry 31, 9025-9030.
4. BRIGHAM, K.L., MEYRICK, B., CHRISTMAN, B., MAGNUSON, M., KING, G., and BERRY, L. (1989). In vivo transfection of expression in murine lungs with a functioning prokaryotic gene using a cationic liposome vehicle. Am. J. Med. Sci. 298, 278-281.
5. CAPLEN, N.J., ALTON, E.W., MIDDLETON, P.G., DORIN, J.R., STEVENSON, B.J., GAO, X., DURHAM, S.R., JEFFERY, P.K., HODSON, M.E., COUTELLE, C., HUANG, L., PORTEOUS, D.J., WILLIAMSON, R., and GEDDES, D. (1995). Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med. 1, 39-46. [See comments; published erratum appears in Nature Med. 1995; 1(3):272.]
6. CHADWICK, S.L., KINGSTON, H.D., STERN, M., COOK, R.M., O'CONNOR, B.J., LUKASSON, M., BALFOUR, R.P., ROSENBERG, M., CHENG, S.H., SMITH, A.E., MEEKER, D.P., GEDDES, D.M., and ALTON, E.W. (1997). Safety of a single aerosol administration of escalating doses of the cationic lipid GL-67/DOPE/DMPE-PEG5000 formulation to the lungs of normal volunteers. Gene Ther. 4, 937-942.
7. FELGNER, P.L., GADEK, T.R., HOLM, M., ROMAN, R., CHAN, H.W., WENZ, M., NORTHROP, J.P., RINGOLD, G.M., and DANIELSEN, M. (1987). Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. U.S.A. 84, 7413-7417.
8. FELGNER, P.L., BARENHOLZ, Y., BEHR, J.P., CHENG, S.H., CULLIS, P., HUANG, L., JESSEE, J.A., SEYMOUR, L., SZOKA, F., THIERRY, A.R., WAGNER, E., and WU, G. (1997). Nomenclature for synthetic gene delivery systems. Hum. Gene Ther. 8, 511-512. [Editorial].
9. FOSTER, B.C., GALLICANO, K.D., WHITEHOUSE, L.W., McGILVERAY, I.J., and KHAN, S.R. (1990). Dextran sulfate disposition in the rat. Biopharm. Drug Disp. 11, 595-606.
10. FREIMARK, B.D., BLEZINGER, H.P., FLORACK, V.I., NORDSTROM, J.L., LONG, S.D., DESHPANDE, D.S., NOCHUMSON, S., and PETRAK, K.L. (1998). Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: Cationic lipid complexes. J. Immunol. 160, 4580-4586.
11. GAO, X., and HUANG, L. (1995). Cationic liposome-mediated gene transfer. Gene Ther. 2, 710-722.
12. HUI, S.W., LANGNER, M., ZHAO, Y.L., ROSS, P., HURLEY, E., and CHAN, K. (1996). The role of helper lipids in cationic liposome-mediated gene transfer. Biophys. J. 71, 590-599.
13. JI, Z.S., DICHEK, H.L., MIRANDA, R.D., and MAHLEY, R.W. (1997). Heparan sulfate proteoglycans participate in hepatic lipase-and apolipoprotein E-mediated binding and uptake of plasma liproproteins, including high density lipoproteins. J. Biol. Chem. 272, 31285-31292.
14. KAWABATA, K., TAKAKURA, Y., and HASHIDA, M. (1995). The fate of plasmid DNA after intravenous injection in mice: Involvement of scavenger receptors in its hepatic uptake. Pharm. Res. 12, 825-830.
15. LEE, E.R., MARSHALL, J., SIEGEL, C.S., JIANG, C., YEW, N.S., NICHOLS, M.R., NIETUPSKI, J.B., ZIEGLER, R.J., LANE, M.B., WANG, K.X., WAN, N.C., SCHEULE, R.K., HARRIS, D.J., SMITH, A.E., and CHENG, S.H. (1996). Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum. Gene Ther. 7, 1701-1717.
16. LEGENDRE, J.Y., and SZOKA, F.C., JR. (1992). Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: Comparison with cationic liposomes. Pharm. Res. 9, 1235-1242.
17. LIU, F., QI, H., HUANG, L., and LIU, D. (1997). Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration. Gene Ther. 4, 517-523.
18. LIU, Y., MOUNKES, L.C., LIGGITT, H.D., BROWN, C.S., SOLODIN, I., HEATH, T.D., and DEBS, R.J. (1997). Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nature Biotech. 15, 167-173.
19. MAHATO, R.I., ANWER, K., TAGLIAFERRI, F., MEANEY, C., LEONARD, P., WADHWA, M.S., LOGAN, M., FRENCH, M., and ROLLAND, A. (1998). Biodistribution and gene expression of lipid/plasmid complexes after systemic administration. Hum. Gene. Ther. 9, 2083-2099.
20. McLACHLAN, G., HO, L.P., DAVIDSON-SMITH, H., SAMWAYS, J., DAVIDSON, H., STEVENSON, B.J., CAROTHERS, A.D., ALTON, E.W., MIDDLETON, P.G., SMITH, S.N., KALLMEYER, G., MICHAELIS, U., SEEBER, S., NAUJOKS, K., GREENING, A.P., INNES, J.A., DORIN, J.R., and PORTEOUS, D.J. (1996). Laboratory and clinical studies in support of cystic fibrosis gene therapy using pCMV-CFTR-DOTAP. Gene Ther. 3, 1113-1123.
21. McLEAN, J.W., FOX, E.A., BALUK, P., BOLTON, P.B., HASKELL, A., PEARLMAN, R., THURSTON, G., UMEMOTO, E.Y., and McDONALD, D.M. (1997). Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am. J. Physiol. 273, H387-H404.
22. MEYER, K.B., THOMPSON, M.M., LEVY, M.Y., BARRON, L.G., and SZOKA, F.C., JR. (1995). Intratracheal gene delivery to the mouse airway: Characterization of plasmid DNA expression and pharmacokinetics. Gene Ther. 2, 450-460.
23. MISLICK, K.A., and BALDESCHWIELER, J.D. (1996). Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc. Natl. Acad. Sci. U.S.A. 93, 12349-12354.
24. MOUNKES, L.C., ZHONG, W., CIPRES-PALACIN, G., HEATH, T.D., and DEBS, R.J. (1998). Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo. J. Biol. Chem. 273, 26164-26170.
25. NABEL, G.J., NABEL, E.G., YANG, Z.Y., FOX, B.A., PLAUTZ, G.E., GAO, X., HUANG, L., SHU, S., GORDON, D., and CHANG, A.E. (1993). Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans. Proc. Natl. Acad. Sci. U.S.A. 90, 11307-11311.
26. NABEL, G.J., CHANG, A.E., NABEL, E.G., PLAUTZ, G.E., ENSMINGER, W., FOX, B.A., FELGNER, P., SHU, S., and CHO, K. (1994). Immunotherapy for cancer by direct gene transfer into tumors. Hum. Gene Ther. 5, 57-77.
27. POLLARD, H., REMY, J.S., LOUSSOUARN, G., DEMOLOMBE, S., BEHR, J.P., and ESCANDE, D. (1998). Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J. Biol. Chem. 273, 7507-7511.
28. SAMBROOK, J., FRITSCH, E., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual. (Cold Spring Harbor Press, Cold Spring Harbor, NY.)
29. SCHEULE, R.K., ST. GEORGE, J.A., BAGLEY, R.G., MARSHALL, J., KAPLAN, J.M., AKITA, G.Y., WANG, K.X., LEE, E.R., HARRIS, D.J., JIANG, C., YEW, N.S., SMITH, A.E., and CHENG, S.H. (1997). Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum. Gene Ther. 8, 689-707.
30. SONG, Y.K., LIU, F., CHU, S., and LIU, D. (1997). Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. Hum. Gene Ther. 8, 1585-1594.
31. SONG, Y.K., LIU, F., and LIU, D. (1998). Enhanced gene expression in mouse lung by prolonging the retention time of intravenously injected plasmid DNA. Gene Ther. 5, 1531-1537.
32. SORSCHER, E.J., LOGAN, J.J., FRIZZELL, R.A., LYRENE, R.K., BEBOK, Z., DONG, J.Y., DUVALL, M.D., FELGNER, P.L., MATALON, S., WALKER, L., and WIATRAK, B.J. (1994). Gene therapy for cystic fibrosis using cationic liposome mediated gene transfer: A phase I trial of safety and efficacy in the nasal airway. Hum. Gene Ther. 5, 1259-1277.
33. STOPECK, A.T., HERSH, E.M., AKPORIAYE, E.T., HARRIS, D.T., GROGAN, T., UNGER, E., WARNEKE, J., SCHLUTER, S.F., and STAHL, S. (1997). Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B&, in patients with metastatic melanoma. J. Clin. Oncol. 15, 341-349.
34. SZOKA, F.C., JR., XU, Y., and ZELPHATI, O. (1996). How are nucleic acids released in cells from cationic lipid-nucleic acid complexes? J. Liposome Res. 6, 567-587.
35. WILLIAMS, K.J., FLESS, G.M., PETRIE, K.A., SNYDER, M.L., BROCIA, R.W., and SWENSON, T.L. (1992). Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. J. Biol. Chem. 267, 13284-13292.
36. XU, Y., and SZOKA, F.C., JR. (1996). Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 35, 5616-5623.
37. ZABNER, J., FASBENDER, A.J., MONINGER, T., POELLINGER, K.A., and WELSH, M.J. (1995). Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270, 18997-19007.
38. ZELPHATI, O., and SZOKA, F.C., JR. (1997). Cationic liposomes as an oligonucleotide carrier: Mechanism of action. J. Liposome Res. 7, 31-49.